Key facts
- This page summarizes Robert John White's Form 4 filing for Medtronic plc (MDT).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 Aug 2023, 20:22.
Robert John White - 31 Jul 2023 Form 4 Insider Report for Medtronic plc (MDT)
- Reporting relationship
- EVP & Pres. Medical Surgical
- Issuer ticker
- MDT
- Reported as of
- 31 Jul 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Aug 2023, 20:22:04 UTC
- Prior SEC filing
- 09 Dec 2022
- Next SEC filing
- 07 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas L. Osteraas, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert John White filed Form 4 for Medtronic plc (MDT) on 02 Aug 2023.
Change
- Previous filing in this sequence was filed on 09 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDT
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +9,116
- Change %
- +25%
- Price
- $0.000000
- Shares after
- 46,156
- Date
- 31 Jul 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDT
transaction
Derivative
Performance Share Units
Award
- Transaction value
- $0
- Shares
- +22,790
- Change %
- Price
- $0.000000
- Shares after
- 22,790
- Date
- 31 Jul 2023
- Ownership
- Direct
- Underlying class
- Performance Share Unit
- Underlying amount
- 22,790
- Exercise price
- Footnotes
- F3, F4, F5
MDT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +64,185
- Change %
- Price
- $0.000000
- Shares after
- 64,185
- Date
- 31 Jul 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 64,185
- Exercise price
- $87.76
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
Footnote F2
Includes 544 units acquired through dividend reinvestment and 310 units acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.
Footnote F3
Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
Footnote F4
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 22,790 shares will be issued. If maximum performance metrics are achieved, 45,580 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Footnote F5
Vests on July 31, 2026.
Footnote F6
These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant.